Osmotic Fragility Test is conducted at Molecular Diagnostics and Therapy, which is an advanced diagnostic centre & an NABL- and NABH–accredited diagnostic centre, that helps in determining the ability of the RBC to 'stand up' vis-à-vissolutionsn of varying salt concentration. Used in the investigation of some inherited and acquired blood disorders to evaluate the membrane stability of red blood cells.
This test is performed using a blood sample. It assesses the resistance of blood to changes in saline. The higher the concentration of the solution, the more water will be taken into the red blood cells. As the concentration of the solution increases, the red blood cells will swell. Eventually, once there is too much water in the red blood cells, they rupture. This test determines the concentration of solution at which the red blood cells begin to lyse and when they stop lysing. Increased osmotic fragility (as seen in thalassaemia) is less common. Other blood tests and findings will be used in combination with this result to aid interpretation.
If there is a fault in one of the proteins of the cell membrane, or if the shape of the cell is altered, the red blood cells will no longer be disc-shaped as normal. They will be spherical. These cells are more fragile and therefore more prone to break down. They are more susceptible to being damaged by the presence of more water.
This is a type of anaemia caused by a reduction in red blood cells (RBCs). This can be caused by destruction of red blood cells and the new production not keeping up. In cases where there is suspected damage to the membrane of red blood cells, this test can be useful.
Thalassaemia is a blood disorder that can cause issues with production of haemoglobin. It is inherited from parents. Some types of thalassaemia may result in decreased osmotic fragility of red blood cells. However, additional information may be gained from this test, but it cannot be used to make a diagnosis.
Inherited disorders can cause changes in the structure, shape and stability of red blood cells. Osmotic fragility can be used to help assess these changes as part of a wider investigation into haematological disorders.
Molecular Diagnostics and Therapy combines Radiology, Nuclear Medicine and Pathology. Careful handling of samples, a standardised procedure within the lab, and suitable quality control mean reliable results. Detailed investigations and accurate reporting allow doctors to gain an understanding of osmotic fragility results in conjunction with other blood tests. We put patients first and offer reliable diagnostic support.
To have this test performed at Molecular Diagnostics and Therapy, please contact us. Ensure that you follow the instructions provided to collect the blood sample. If possible, bring a prescription from your doctor, relevant patient notes, previous full blood count results, and peripheral blood smear results. Usually, fasting is not required. Please check with the lab for any specific preparation instructions.
Test information: Fasting NOT needed
Reporting: Within 24 hours*